The Bulletin
The Times


.

UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics

  • Written by PR Newswire

SHENZHEN, China, Aug. 29, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company"), which continues to build on its strengths in the global healthcare sector, has announced that it has commenced a comprehensive financial and legal due diligence on Bowen Therapeutics Inc ("Bowen Therapeutics"), which it intends to acquire....

hacklink esim balkanzlibraryzlibrarySahabetuk casinos not on gamstopGamStopgrandpashabet girişviagra 100 mg fiyattaraftarium24taraftarium24extrabet